Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
132.9 USD | +0.17% | +13.29% | +33.63% |
May. 17 | Moderna Insider Sold Shares Worth $1,912,350, According to a Recent SEC Filing | MT |
May. 17 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
Financials (USD)
Sales 2024 * | 4.18B | Sales 2025 * | 4.84B | Capitalization | 50.93B |
---|---|---|---|---|---|
Net income 2024 * | -2.7B | Net income 2025 * | -1.97B | EV / Sales 2024 * | 10.7 x |
Net cash position 2024 * | 6.25B | Net cash position 2025 * | 3.94B | EV / Sales 2025 * | 9.71 x |
P/E ratio 2024 * |
-18.8
x | P/E ratio 2025 * |
-25.9
x | Employees | 5,600 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.41% |
Latest transcript on Moderna, Inc.
1 day | +0.17% | ||
1 week | +13.29% | ||
Current month | +20.48% | ||
1 month | +28.48% | ||
3 months | +50.39% | ||
6 months | +73.86% | ||
Current year | +33.63% |
Managers | Title | Age | Since |
---|---|---|---|
Stéphane Bancel
CEO | Chief Executive Officer | 51 | 11-02-28 |
James Mock
DFI | Director of Finance/CFO | 47 | 22-09-05 |
Stephen Hoge
PSD | President | 48 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Sagan
BRD | Director/Board Member | 65 | 18-05-31 |
Director/Board Member | 74 | 20-06-30 | |
Francois Nader
BRD | Director/Board Member | 67 | 19-12-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
5.66% | 0 M€ | 0.00% | - | |
4.69% | 2 M€ | -.--% | ||
4.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 132.9 | +0.17% | 2,718,168 |
24-05-16 | 132.7 | +2.80% | 3,008,046 |
24-05-15 | 129.1 | +0.58% | 2,964,702 |
24-05-14 | 128.3 | +2.11% | 3,625,381 |
24-05-13 | 125.7 | +7.13% | 4,095,239 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- MRNA Stock